quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:31:23·99d
SECFiling
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

ORMP· Oramed Pharmaceuticals Inc.
Health Care
Original source

Companies

  • ORMP
    Oramed Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Jan 12UpdateCanaccord Genuity$3.00
  • Feb 18UpdateCantor Fitzgerald$20.00
  • Nov 30UpdateHC Wainwright & Co.$32.00
  • Nov 29UpdateHC Wainwright & Co.$32.00
  • Nov 2UpdateAegis Capital$35.00
  • Jul 29UpdateCanaccord Genuity$30.00

Related

  • SEC23d
    Oramed Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets
  • INSIDER23d
    SEC Form 4 filed by Kidron Nadav
  • INSIDER23d
    SEC Form 4 filed by Kidron Miriam
  • SEC28d
    SEC Form 10-K filed by Oramed Pharmaceuticals Inc.
  • PR29d
    Lifeward Successfully Closes on Strategic Partnership with Oramed
  • INSIDER36d
    SEC Form 4 filed by Gabay Avraham
  • INSIDER36d
    SEC Form 4 filed by Hexter Joshua
  • INSIDER36d
    SEC Form 4 filed by Kidron Miriam
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022